Therapeutic methods and uses for antibodies to human MASP-3
TW202629602APending Publication Date: 2026-07-16NOVO NORDISK HEALTH CARE AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114145129
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-04
- Filing Date
- 2025-11-19
- Publication Date
- 2026-07-16
Abstract
Methods of treating paroxysmal nocturnal hemoglobinuria using MASP-3 serine protease inhibitors are provided. In some embodiments, the MASP-3 serine protease inhibitors are anti-MASP-3 antibodies. Also provided are uses of MASP-3 serine protease inhibitors in treatment of paroxysmal nocturnal hemoglobinuria, and for manufacture of a medicament for treatment of paroxysmal nocturnal hemoglobinuria.
Need to check novelty before this filing date? Find Prior Art